Prognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors
- 1 January 1999
- journal article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 23 (1) , 82-87
- https://doi.org/10.1097/00000478-199901000-00009
Abstract
Although the significance of various prognostic factors, such as tumor size and mitotic index (MI), has been well established for smooth-muscle tumors of the stomach, the significance of these factors in other sites is less well defined. We studied 1004 patients with gastrointestinal smooth-muscle tumors for whom vital status could be determined. The average MI and tumor size varied significantly among the five major sites examined: esophagus (53 cases), stomach (524 cases), small bowel 252 cases), colon/rectum (108 cases), and omentum/mesentery/peritoneum (67 cases). There was a significant difference in site-specific survival (p = 0.001), with 10-year survival varying between 50% and 70%. Multivariate analysis demonstrated tumor location (p = 0.0320), size (p = 0.0003), MI (p < 0.0001), and patient age (p < 0.0001) to each carry independent prognostic value. The significance of MI was highly site dependent. Separation of survival curves for the stomach, using a threshold for analysis of either 5 or 10 mitotic figures/50 high-power fields, was very good. In contrast, small-bowel tumors showed little separation between survival curves, regardless of whether a threshold of 1, 5, or 10 mitotic figures MF/50 high-power fields was used to distinguish groups. In no site were tumor size and MI alone sufficient to provide an accurate long-term prediction of prognosis. Although tumor location, size, MI, and age have independent value in predicting the prognosis of patients with gastrointestinal smooth-muscle tumors, better methods are still required to accurately predict clinical course.Keywords
This publication has 30 references indexed in Scilit:
- Stromal Tumors of the Jejunum and IleumThe American Journal of Surgical Pathology, 1997
- Artificial neural networks improve the accuracy of cancer survival predictionCancer, 1997
- Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumorsHuman Pathology, 1997
- Smooth muscle tumors of the gastrointestinal tract: Analysis of prognostic factorsSurgery, 1996
- Differentiation and Risk Assessment of Gastrointestinal Stromal TumorsAmerican Journal of Clinical Pathology, 1995
- Predicting Prognosis of Gastrointestinal Smooth Muscle TumorsThe American Journal of Surgical Pathology, 1993
- A Flow Cytometric, Clinical, and Histological Study of Stromal Neoplasms of the Gastrointestinal TractThe American Journal of Surgical Pathology, 1992
- Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 yearsCancer, 1985
- Sarcomas of the StomachAmerican Journal of Clinical Pathology, 1977
- Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma)Cancer, 1976